Loading clinical trials...
Loading clinical trials...
Validating the Accuracy of the Airvo 3 Device for Continuous Respiratory Rate Monitoring in Healthy Adults and Chronic Obstructive Pulmonary Disease (COPD) Patients: Comparison With a Reference Benchmark
Conditions
Interventions
Airvo 3 with respiratory rate algorithm
Locations
1
United States
Element Boulder
Louisville, Colorado, United States
Start Date
April 1, 2024
Primary Completion Date
October 1, 2024
Completion Date
October 1, 2024
Last Updated
March 26, 2024
NCT00104325
NCT07118891
NCT01399385
NCT07307781
NCT07383896
NCT07295717
Lead Sponsor
Fisher and Paykel Healthcare
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions